VENU Venu posts wider than expected Q4 2025 loss sending its stock down 483 percent in todays trading SFC Stifel confirms steady preferred Series C payout levels as core business segments remain stable this quarter Sensei Biotherapeutics SNSE Stock Risk vs Return Evaluation Q4 2025 EPS Exceeds Expectations Tillys TLYS Stock Reversal Trend Strengthens 20260420 Rubico RUBI Stock Protective Put Eye on Rally 20260420